Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment- long-term observation in CML Study IV

Miranda, M. B.; Lauseker, M.; Kraus, M.-P.; Proetel, U.; Hanfstein, B.; Fabarius, A.; Baerlocher, G. M.; Heim, D.; Krause, S. W.; Hossfeld, D. K.; Nerl, C.; Kolb, H.-J.; Brümmendorf, T. H.; Verbeek, W.; Fauser, A. A.; Prümmer, O.; Neben, K.; Hess, U.; Mahlberg, R.; Plöger, C.; Flasshove, M.; Rendenbach, B.; Hofmann, W.-K.; Müller, M. C.; Pfirrmann, M.; Hochhaus, A.; Hasford, J.; Hehlmann, R.; Saußele, S.

Published in

Springer Nature [academic journals on nature.com], Leukemia, 6(30), p. 1255-1262, 2016

DOI: 10.1038/leu.2016.20

Tools

Export citation

Search in Google Scholar

Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment- long-term observation in CML Study IV

Journal article published in 2016 by M. B. Miranda, M. Lauseker, M.-P. Kraus, U. Proetel, B. Hanfstein, A. Fabarius, G. M. Baerlocher, D. Heim, S. W. Krause

, D. K. Hossfeld, C. Nerl, H.-J. Kolb, T. H. Brümmendorf, W. Verbeek, A. A. Fauser and other authors.

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by

Published in

Links

Tools

Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment- long-term observation in CML Study IV